Comparison analysis of FIB-4, LIVERFASt, LSM in Sequential and Combinatory Pathways for NAFLD easlfibronostg on June 26, 2026 Category: Publications Tag: Clinical Pathway, Identification, LIVERFASt, MASLD, NAFLD Post navigation Previous: Previous post: Long-term prognosis of MAFLD patients according to non-invasive methodsNext: Next post: Simulating clinical confidence intervals for black-box algorithmic predictions of liver steatosis
